Authors: Gupta, D Shidham, V Holden, J Layfield, L

Citation: D. Gupta et al., Value of topoisomerase II alpha, MIB-1, p53, E-cadherin, retinoblastoma gene protein product, and HER-2/neu immunohistochemical expression for the prediction of biologic behavior in adrenocortical neoplasms, APPL IMMUNO, 9(3), 2001, pp. 215-221

Authors: Gupta, D Holden, J Layfield, L

Citation: D. Gupta et al., Topoisomerase alpha II, retinoblastoma gene product, and p53: Potential relationships with aggressive behavior and malignant transformation in recurrent respiratory papillomatosis, APPL IMMUNO, 9(1), 2001, pp. 86-91

Authors: Cessna, MH Zhou, H Perkins, SL Tripp, SR Layfield, L Daines, C Coffin, CM

Citation: Mh. Cessna et al., Are myogenin and MyoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics, AM J SURG P, 25(9), 2001, pp. 1150-1157

Authors: Tomaszewski, JE Bear, HD Connally, JA Epstein, JI Feldman, M Foucar, K Layfield, L LiVolsi, V Sirota, RL Stoler, MH Stombler, RE

Citation: Je. Tomaszewski et al., Consensus conference on second opinions in diagnostic anatomic pathology -Who, what, and when, AM J CLIN P, 114(3), 2000, pp. 329-335

Authors: Gupta, D Shidham, V Holden, J Layfield, L

Citation: D. Gupta et al., Prognostic value of immunohistochemical expression of topoisomerase alpha II, MTB-1, p53,E-cadherin, retinoblastoma gene protein product, and HER-2/neu in adrenal and extra-adrenal pheochromocytomas, APPL IMMUNO, 8(4), 2000, pp. 267-274

Authors: Prosnitz, LR Maguire, P Anderson, JM Scully, SP Harrelson, JM Jones, EL Dewhirst, M Samulski, TV Powers, BW Rosner, GL Dodge, RK Layfield, L Clough, R Brizel, DM

Citation: Lr. Prosnitz et al., The treatment of high-grade soft tissue sarcomas with preoperative thermoradiotherapy, INT J RAD O, 45(4), 1999, pp. 941-949